QAQC Johns Hopkins Institute for Clinical and Translational Research

本行政副刊的目的是设立质量保证/质量控制职位 是为了确保高质量地提交给NCATS的事先审批程序。具体目标 详情如下： 1)确保遵守NIH和NCATS关于CTSA相关提交的政策 NCATS和提交给ERA人类学科系统，并参与 整个CTSA联合体的流程改进。 2)提高所有伙伴机构提交的事先核准的质量 试点奖励和KL2项目，减少不准确和不完整的信息 意见书 3)在提交给NCATS之前实施正式的质量审查流程。 4)为提交给人类时代的文件制定集中管理流程 科目体系，以确保一致性、准确性和效率。 5)审查和汇编任何问题提交领域的数据，并制定纠正措施 行动计划。 这将通过拥有专门的研究导航员来实现，该导航员将确保 具体的目标不仅在约翰·霍普金斯大学(JH)而且在合作伙伴那里得到实施和遵循 机构也是如此。为了确保JH和马里兰大学的一致性，这项研究 领航员职位将在两家机构之间分别平分75%和25%，以允许 为了一个协调、有凝聚力、高质量的过程。

The objective of this Administrative Supplement for a Quality Assurance/Quality Control position is to ensure high quality submissions to the NCATS prior approval process. The specific aims are as follows: 1) Ensure adherence to NIH and NCATS policies regarding CTSA-related submissions to NCATS and submissions to the eRA Human Subjects System, and participate in process improvement across the CTSA consortium. 2) Improve the quality of the prior approval submissions across all partner institutions for Pilot awards and KL2 projects by reducing inaccurate information and incomplete submissions 3) Implement a formal quality review process prior to submission to NCATS. 4) Develop a centralized management process for submissions to the eRA Human Subjects System to ensure consistency, accuracy, and efficiency. 5) Review and compile data on any problem submission areas and develop corrective action plans. This will be accomplished by having a dedicated Research Navigator who will ensure these specific aims are implemented and followed not only at Johns Hopkins (JH) but at partner institutions also. To ensure consistency across JH and University of Maryland, the Research Navigator position will be split between the two institutions 75% and 25%, respectively, to allow for a well-coordinated, cohesive, high-quality process.